Medpace leads structurally, with profitability as the clearest single gap between the two profiles. On the market side, Medpace is in better shape — its trend is intact while Neurocrine Biosciences's trend has broken down. That puts structure and market broadly in agreement — Medpace's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
The comparison is mainly decided in profitability, with the rest of the profile carrying less weight. The overall score gap is 14 points in favour of Medpace Holdings, Inc..
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
The strongest overlap appears in investment intensity and recent revenue growth.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in profitability.
Left means cheaper relative valuation. Higher means stronger structure.
Medpace Holdings, Inc. is stronger, but the price setup still looks more supportive for Neurocrine Biosciences, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Capital efficiency adds support, with a 430-point ROIC advantage.
Neurocrine Biosciences, Inc. still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.
Profitability clearly separates the pair, while the broader read stays strong rather than one-way.
Break down the MEDP vs NBIX comparison across all dimensions with the full interactive tool.
Explore how MEDP and NBIX each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.